文献速递骨肌技术与安全CT

多发性骨髓瘤干细胞移植患者CT所示低相对肌肉量与骨损伤的关系

CT-derived relationship between low relative muscle mass and bone damage in patients with multiple myeloma undergoing stem cells transplantation.
PubMed 文献 · Br J Radiol · 2021-12-21

本研究纳入74例接受干细胞移植的多发性骨髓瘤患者,利用CT测量的骨骼肌指数(SMI<41 cm²/m²定义肌少症)和骨髓瘤脊柱与骨损伤评分(MSBDS)评估肌肉量与骨损伤的关系。结果显示肌少症与骨损伤升高显著相关,但SMI和MSBDS均与总生存无显著关联。

要点

  • CT定义的肌少症(SMI<41 cm²/m²)与多发性骨髓瘤患者骨损伤升高显著相关。
  • 肌少症在女性患者中更常见(p=.001)。
  • SMI和MSBDS均与总生存无显著关联。

核心结论

  • 肌少症和骨损伤影响接受干细胞移植的多发性骨髓瘤患者,且两者显著相关。
  • CT定量测量肌少症和骨损伤在接受干细胞移植的多发性骨髓瘤患者中存在且显著相关。

研究设计与样本

  • 经机构审查委员会批准的研究,纳入74例连续接受移植的多发性骨髓瘤患者,平均年龄60.8岁±9.24(标准差),范围36-89岁。
  • 肌少症截断值定义为骨骼肌指数(SMI)<41 cm²/m²。
  • 采用骨髓瘤脊柱与骨损伤评分(MSBDS)评估骨损伤。
  • 使用单因素方差分析和X²检验,Kaplan-Meier分析生成进展和生存曲线,检验水准设为0.05。

诊断标准与关键数值

  • 肌少症截断值:骨骼肌指数(SMI)<41 cm²/m²。
  • 骨损伤评估采用MSBDS(骨髓瘤脊柱与骨损伤评分)。
  • SMI中位数为47.1±14.2,18/74(24%)存在肌少症。
  • 低肌肉量且骨损伤升高者24/74(32.4%),正常/非低肌肉量且低骨损伤者30/74(40.5%),两者强且显著相关。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Sarcopenia or low muscle mass is related to worse prognosis in cancer patients. We investigated whether muscle mass is related to bone damage on CT in patients with multiple myeloma (MM).

METHODS: Approval from the institutional review board was obtained. N = 74 consecutive patients (mean age, 60.8 years ± 9.24 [standard deviation]; range, 36-89 years) for MM who underwent transplant were included. Sarcopenia cut-off points defined as skeletal muscle index (SMI) used were<41 cm2/m2. To assess bone damage in MM the MSBDS (myeloma spine and bone damage score) was used. One-way analysis of variance and the X2 test were used. Kaplan-Meier analysis was performed to generate progression and survival curves according to SMI and MSBDS. The testing level was set at 0.05.

RESULTS: The median SMI was 47.1 ± 14.2 and according to SMI 18/74 (24%) had sarcopenia which was more prevalent in females (p.001). A strong and significant association between patients with low muscle mass and elevated bone damage (24/74, 32.4%) and patients with normal/non-low muscle mass low bone damage (30/74, 40.5%) was present. Multiple Logistic regression did not show any significant relationship or confounding influence among SMI and MSBDS regarding sex (p.127), cytogenetic status (p.457), staging (p.756) and relapse (.126). Neither SMI nor MSBDS resulted significantly related to overall survival as shown in Kaplan-Meier analysis.

CONCLUSION: Sarcopenia and bone damage affected MM patients undergoing stem cell transplantation and are significantly associated.

ADVANCES IN KNOWLEDGE: Quantitative measurement of sarcopenia and bone damage on CT resulted present in MM patients undergoing stem cell transplantation and are significantly associated.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Tagliafico, Rossi, Bignotti, et al. CT-derived relationship between low relative muscle mass and bone damage in patients with multiple myeloma undergoing stem cells transplantation. Br J Radiol. 2021. PMID: 34918544. doi:10.1259/bjr.20210923

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。